Cargando…
A Strategy to Battle Coronavirus Disease 2019 in the Hospital: Identify and Use the Power of “Immune Survivors”
The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses serious health and economic problems worldwide. One of the worst scenarios is the collapse of the medical care system due to nosocomial infections. SARS-CoV-2 quickly spreads in closed spaces, crowded areas, and c...
Autores principales: | Yamamoto, Hironori, Miura, Kouichi, Hagiwara, Koichi, Morisawa, Yuji, Lefor, Alan Kawarai, Sata, Naohiro, Nagai, Ryozo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676985/ https://www.ncbi.nlm.nih.gov/pubmed/33225101 http://dx.doi.org/10.31662/jmaj.2020-0039 |
Ejemplares similares
-
Low prevalence of SARS‐CoV‐2 specific antibodies among endoscopists and their assistants in a university hospital in Tochigi prefecture–A single‐center study
por: Miura, Kouichi, et al.
Publicado: (2021) -
Novel Drug Delivery Method Targeting Para-Aortic Lymph Nodes by Retrograde Infusion of Paclitaxel into Pigs’ Thoracic Duct
por: Saito, Akira, et al.
Publicado: (2022) -
Non-pharmaceutical strategies win coronavirus disease 2019 battle in New Zealand
por: Nhamo, Godwell, et al.
Publicado: (2020) -
Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022) -
Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study
por: Shinozaki, Satoshi, et al.
Publicado: (2023)